User menu

Myocardial Viability. Limitations and unresolved issues.

Bibliographic reference Wijns, William ; Vanoverschelde, Jean-Louis ; Bol, Anne ; Gerber, Bernhard ; Melin, Jacques. Myocardial Viability. Limitations and unresolved issues.. In: The International Journal of Cardiac Imaging, Vol. 11, no. Supplement 1, p. 85-88 (1995)
Permanent URL
  1. Tillisch et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884?8.
  2. Carrel et al. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992; 6: 479?84.
  3. Dreyfus et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularisation. Ann Thorac Surg 1194; 57: 1402?8.
  4. Marshall et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography F-18 labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1981; 64: 766?78.
  5. Camici et al. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989; 32: 217?38.
  6. Brunken et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951?63.
  7. Tamaki et al. Positron emission tomography using fluorine-18 deoxy glucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860?5.
  8. Marwick et al. Metabolic responses of hibernating and infarcted myocardium to revascularisation. A follow-up study of regional perfusion, function and metabolism. Circulation 1992; 85: 1347?53.
  9. Vanoverscheide et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513?23.
  10. Sebree etal. Discordance between C-14 deoxyglucose and Tl-201 in reperfused myocardium. J Mol Cell Cardiol 1991; 23: 603?16.
  11. Maes et al. Histological alterations in chronically hypoperfused myocardium: correlation with PET findings. Circulation 1994; 90: 735?45.
  12. Depré C et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemie dysfunction in humans. Am J Physiol 1995: in press.
  13. Flameng et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischaemic heart disease: determinants of reversible segmental asynergy postrevascularisation surgery. Am Heart J 1981; 102: 846?57.
  14. Ausma et al. Chronic ischemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol 1995: in press.
  15. Vanoverschelde et al. Time-course of functional recovery of hibernating myocardium after coronary revascularization. Circulation 1994; 90(part 2): I-378. (abstract)
  16. Berry et al. The effect of metabolic milieu on cardiac PET imaging with fluorine-18 deoxy glucose and nitrogen-13 ammonia in normal volunteers. J Nucl Med 1991; 32: 1518?25.
  17. Knuuti et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33: 1255?62.
  18. Gropler etal. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992; 20: 569?77.
  19. Gropler et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992; 19: 989?97.
  20. Goldstein RA. Kinetics of rubidium-82 after coronary occlusion and reperfusion. J Clin Invest 1985; 75: 1131?6.
  21. Gould et al. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity from the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991; 32: 1?9.
  22. Iida et al. Myocardial tissue fraction: correction for partial volume effects and measure of tissue viability. J Nucl Med 1991; 32: 2169?75.
  23. Yamamoto et al. A new strategy for the assessment of viable and regional myocardial blood flow using15O-water and dynamic positron emission tomography. Circulation 1992; 86: 167?78.
  24. De Silva et al. Preoperative prediction of the outcome of coronary revascularisation using positron emission tomography. Circulation 1992; 86: 1738?42.
  25. Parodi et al. Cardiac emission computed tomography: underestimation of regional tracer concentrations due to wall motion abnormalities. J Comput Assist Tomography 1984; 8: 1083?92.
  26. Marinho et al. Hibernating myocardium: is it really due to chronic hypoperfusion. Circulation 1994; 90 (part 2): I-314. (abstract)
  27. Gerber et al. Prediction of viable myocardium by 0-15 water and N-13 ammonia quantitative PET: which are the parameters to derive. Eur J Nucl Med 1994; 21: 725. (abstract)
  28. Bax et al. Feasibility of assessing regional myocardial uptake of18F-fluorodeoxyglucose using single photon emission computed tomography. Eur Heart J 1993; 14: 1677?82.
  29. Pierard et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021?31.
  30. Cigarroa et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430?6.
  31. Vanoverschelde et al. How to select coronary patients with poor left ventricular ejection fraction who should undergo coronary revascularization? Circulation 1994; 90 (part 2): I-252. (abstract)
  32. Gerber et al. Dobutamine echocardiography,201Thallium SPECT and positron emission tomography: which test for the prediction of myocardial viability? Circulation 1994; 90 (part 2): I-314. (abstract)